These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 14287991)

  • 1. CHEMICAL PHARMACOLOGY OF 2-SULFANILAMIDO-3-METHOXYPYRAZINE.
    WIEGAND RG; CHUN AH; SCHERFLING E; LOPEZ F; HERTING RL
    Antimicrob Agents Chemother (Bethesda); 1964; 10():549-53. PubMed ID: 14287991
    [No Abstract]   [Full Text] [Related]  

  • 2. [ON THE PHARMACOKINETICS OF A LONG-ACTING SULFONAMIDE (4-SULFANILAMIDO-5,6-DIMETHOXYPYRIMIDINE) IN NORMAL PERSONS].
    PORTWICH F; BUETTNER H
    Klin Wochenschr; 1964 Aug; 42():740-4. PubMed ID: 14296354
    [No Abstract]   [Full Text] [Related]  

  • 3. CLINICAL PHARMACOLOGY OF 2-SULFANILAMIDO-3-METHOXYPYRAZINE.
    HERTING RL; LOPEZ F; SCHERFLING E; SYLVESTER JC; WIEGAND R
    Antimicrob Agents Chemother (Bethesda); 1964; 10():554-61. PubMed ID: 14287992
    [No Abstract]   [Full Text] [Related]  

  • 4. [S-Sulfanilamido- and 3-sulfanilamido-1,2,4-thiadiazole].
    WOERFFEL U; BEHNISCH R
    Arch Pharm Ber Dtsch Pharm Ges; 1962 Nov; 295/67():811-6. PubMed ID: 14001457
    [No Abstract]   [Full Text] [Related]  

  • 5. [2-Sulfanilamido-3-methoxypyrazine. Chemical, physicochemical, biological and therapeutic characteristics].
    ROCCHIETTA S
    Boll Chim Farm; 1961 Apr; 100():279-81. PubMed ID: 13742397
    [No Abstract]   [Full Text] [Related]  

  • 6. The efficacy of 4-sulfanilamido-6-methoxypyrimidine in standardized infections in mice.
    REDIN GS; McCOY ME
    Chemotherapia (Basel); 1962; 4():386-97. PubMed ID: 14490938
    [No Abstract]   [Full Text] [Related]  

  • 7. [Study of the kinetics, elimination & transit of gantrisin (3,4-dimethyl-5-sulfanilamido-isoazole). I].
    LAPP C
    Clin Chim Acta; 1957 Oct; 2(5):429-41. PubMed ID: 13489880
    [No Abstract]   [Full Text] [Related]  

  • 8. SERUM CONCENTRATION AND ANTIBACTERIAL ACTIVITY OF 4-SULFANILAMIDO-5,6DIMETHOXYPYRIMIDINE.
    MADSEN ST
    Am J Med Sci; 1964 Feb; 247():217-22. PubMed ID: 14124711
    [No Abstract]   [Full Text] [Related]  

  • 9. [ON PHARMACOKINETICS OF SULFONAMIDES UNDER PATHOLOGICAL CONDITIONS].
    BUETTNER H; PORTWICH F; MANZKE E; STAUDT N
    Klin Wochenschr; 1964 Jan; 42():103-8. PubMed ID: 14128387
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies on 3,4-dimethyl-5-sulfanilamido-isoxazole (Nu-445) in humans.
    SARNOFF SJ
    Proc Soc Exp Biol Med; 1948 May; 68(1):23-6. PubMed ID: 18863664
    [No Abstract]   [Full Text] [Related]  

  • 11. Toxicologic and metabolic studies on 2, 4-dimethoxy-6-sulfanilamido-1, 3-diazine (madribon).
    RANDALL LO; BAGDON RE; ENGELBERG R
    Toxicol Appl Pharmacol; 1959 Jan; 1(1):28-37. PubMed ID: 13625313
    [No Abstract]   [Full Text] [Related]  

  • 12. Chemotherapeutic activity of 6-sulfanilamido-2,4-dimethylpyrimidine (elkosin).
    EISMAN PC; GEFTIC SG; LIGENZOWSKI F; MAYER RL
    Proc Soc Exp Biol Med; 1952 Jul; 80(3):493-5. PubMed ID: 14949095
    [No Abstract]   [Full Text] [Related]  

  • 13. Chemotherapeutic studies with 2, 4-dimethoxy-6-sulfanilamido-1, 3-diazine (madribon).
    SCHNITZER RJ; DELORENZO WF; GRUNBERG E; RUSSOMANNO R
    Proc Soc Exp Biol Med; 1958 Nov; 99(2):421-4. PubMed ID: 13601890
    [No Abstract]   [Full Text] [Related]  

  • 14. 2-Sulfanilamido-3-methoxypyrazine: a new long-action sulfonamide.
    CESANA A; VENTURA R
    Panminerva Med; 1962 Apr; 4():184-7. PubMed ID: 13877775
    [No Abstract]   [Full Text] [Related]  

  • 15. The bacteriologicoclinical evaluation of 2,4-dimethoxy-6-sulfanilamido-1, 3-diazine (Madribon) in various urological disorders associated with urinary tract infection.
    SIERP M; DRAPER JW
    Ann N Y Acad Sci; 1959 Sep; 82():92-104. PubMed ID: 14446539
    [No Abstract]   [Full Text] [Related]  

  • 16. The treatment of pneumonia and other infections with a soluble sulfonamide, gantrosan (NU-445; 3,4-dimethyl-5-sulfanilamido-isoxazole).
    BRICKHOUSE RL; LEPPER MH
    Am J Med Sci; 1949 Aug; 218(2):133-7. PubMed ID: 18135998
    [No Abstract]   [Full Text] [Related]  

  • 17. [PHARMACOKINETICS AND CLINICO-THERAPEUTIC EFFECTIVENESS OF 4-SULFANILAMIDO-5,6-DIMETHOXYPYRIMIDINE].
    HITZENBERGER G
    Wien Klin Wochenschr; 1964 May; 76():330-4. PubMed ID: 14222129
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies on the relation of pharmacology and chemotherapeutic effect of some sulfanilamide-derivatives.
    VERHAGEN H
    Acta Med Scand; 1948 Jun; 130(5):436-54. PubMed ID: 18881099
    [No Abstract]   [Full Text] [Related]  

  • 19. Metabolism and binding of N-(2-methyl-6-methoxy-4-pyrimidinyl) sulfanilamide (sulfamethomidine) in man.
    DICARLO FJ; MALAMENT SG; HAYNES LJ; PHILLIPS GE
    Toxicol Appl Pharmacol; 1963 Jan; 5():61-70. PubMed ID: 14027680
    [No Abstract]   [Full Text] [Related]  

  • 20. STUDIES OF SULFAMETHOXYDIAZINE. II. ANTIBACTERIAL ACTIVITY.
    KAPLAN K; CHEW WH; WEINSTEIN L
    Clin Pharmacol Ther; 1965; 6():316-20. PubMed ID: 14296029
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.